ZINEREO PHARMA, S.L.U.

About

Company description

Innovation in Probiotics and CDMO Solutions
At Zinereo Pharma, we are leaders in the development and manufacturing of pharmaceutical-grade probiotics designed to improve health and well-being. Our probiotic product line is built around the concept of Everything starts in the gut. We organize our portfolio according to the different gut-related axes for each therapeutic line: the gut–women’s health axis (covering fertility, gynecology, and female urology), the gut–respiratory axis (addressing both pediatric and adult populations), the gut–immune axis, and others. Our commitment to science and innovation positions us as a benchmark in the probiotics sector.
With over 80 years of experience in the pharmaceutical industry, we combine our expertise in biotechnology and microbiota to offer innovative solutions that make a difference in both human and animal health.
We are proud to offer a portfolio of more than 15 innovative products available in over 20 countries—LATAM, Middle East, Europe, Africa, and Asia—while continuing to develop new solutions for future health challenges. In addition to our probiotic portfolio, we provide customized CDMO services, from development to manufacturing, helping our clients bring their products to market with quality and efficiency.

Quick facts

Sales markets	Africa; Asia; Central/South America; Middle East
Primary business activity	Contract Manufacturer
Affiliated categories:	Other Microorganisms & Probiotics \|Other Prebiotics \|Biotic products More

Upcoming events

5 may 2026

Vitafoods Europe 2026

05 - 07 May 2026 Fira Barcelona Gran Via, Av. Joan Carles I, 64, 08908 L'Hospitalet de Llobregat, Barcelona, Spain Visit us at stand 4H52G Book a meeting See our Exhibitor Profile See full Exhibitor List

Recently at

17 sep 2025

Vitafoods Asia 2025

17 - 19 Sept 2025 Bangkok, Thailand We were at stand N28 See our Exhibitor Profile See full Exhibitor List

20 may 2025

Vitafoods Europe 2025

20 - 22 May 2025 Barcelona, Spain We were at stand 5B48O See our Exhibitor Profile See full Exhibitor List

Our Top products

Otibiome. A unique probiotic solution for the prevention and recurrence of acute otitis media in children.

Otibiome is a food supplement based on Lactobacillus salivarius PS7, an exclusive patented probiotic strain with clinical evidence supporting its efficacy in reducing both the recurrence and severity of acute otitis media episodes — one of the most common diseases in infancy and childhood. The re...

More info

Pharmalactis® Breathe. Triple synergistic action for your respiratory defenses

Pharmalactis® Breathe is a postbiotic food supplement designed to reinforce respiratory defenses. Its synergic formulation combines PostbiotiX® LM-1004 (inactivated Lactobacillus plantarum) , phytonutrients (Propolis and Thyme) , and antioxidants and cytoprotectives (N-acetylcysteine and Vitamin ...

More info

Fertibiome®: A UNIQUE PROBIOTIC SOLUTION TO ENHANCE THE CHANCES OF PREGNANCY SUCCESS IN ASSISTED REPRODUCTIVE TECHNOLOGY

Fertibiome® is an innovative probiotic solution specifically designed to reverse urogenital dysbiosis in couples and improve reproductive health. It is formulated with the exclusive patented strain Ligilactobacillus salivarius PS11610 and is supported by a clinical trial that achieved the following r...

More info

View all our products (10)

News about ZINEREO PHARMA, S.L.U.

23 Feb 2026

Zinereo Pharma Highlights Fertility Innovation at the FFWS-Bangkok

Ana Nunes, Business Unit Director of Microbiome and Probiotics, delivered the keynote "From Microbiota to Fertility," showcasing the clinical efficacy of Fertibiome.

23 Feb 2026

Women’s Health in Dubai-Specialized Training by Ana Nunes

Zinereo Pharma has strengthened its presence in the Middle East with a series of advanced training sessions held in Dubai. Ana Nunes, the company’s Business Unit Director of Microbiome and Probiotics, personally conducted the two-day technical seminar focused on the therapeutic solutions Giniwa and Fertibiome.

19 Jun 2025

Beyond the gut: how Zinereo Pharma is redefining reproductive health

Our Business Unit Director, Ana Nunes, has been featured in Microbiome Post in an interesting interview. In this article, she dives into the origins of Zinereo Pharma, our unique positioning at the intersection of pharmaceutical heritage and biotech innovation, and how we are setting new standards in microbiome-based healthcare, especially in reproductive health.

9 Mar 2025